| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
70,719 |
65,275 |
$8.61M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
53,537 |
50,203 |
$4.48M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
24,933 |
22,629 |
$4.16M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
18,478 |
16,951 |
$1.15M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
26,842 |
24,749 |
$1.05M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,573 |
11,741 |
$436K |
| 80053 |
Comprehensive metabolic panel |
54,662 |
48,276 |
$413K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,384 |
5,922 |
$380K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
61,212 |
53,650 |
$341K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
22,498 |
20,354 |
$329K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
17,387 |
14,606 |
$326K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17,068 |
14,553 |
$313K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,580 |
5,210 |
$285K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
854 |
465 |
$234K |
| 81025 |
|
32,920 |
30,258 |
$218K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
9,778 |
7,607 |
$192K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
1,220 |
755 |
$161K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,550 |
4,549 |
$155K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
5,152 |
4,708 |
$151K |
| 71045 |
Radiologic examination, chest; single view |
8,745 |
7,958 |
$146K |
| 36415 |
Collection of venous blood by venipuncture |
38,265 |
32,486 |
$110K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
4,776 |
4,267 |
$99K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
992 |
965 |
$71K |
| 80050 |
General health panel |
1,798 |
1,724 |
$71K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,389 |
1,282 |
$68K |
| 84484 |
|
8,151 |
6,361 |
$63K |
| 81000 |
|
21,655 |
19,592 |
$61K |
| 71046 |
Radiologic examination, chest; 2 views |
2,986 |
2,813 |
$55K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,263 |
5,757 |
$50K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,532 |
622 |
$49K |
| 80061 |
Lipid panel |
4,179 |
3,930 |
$48K |
| 59025 |
Fetal non-stress test |
427 |
187 |
$35K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
179 |
162 |
$28K |
| 86703 |
|
2,371 |
2,204 |
$26K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,951 |
1,830 |
$26K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13,345 |
12,136 |
$25K |
| 99215 |
Prolong outpt/office vis |
474 |
449 |
$24K |
| 83690 |
|
4,571 |
4,162 |
$23K |
| 82607 |
|
1,681 |
1,577 |
$23K |
| 86803 |
|
1,628 |
1,490 |
$22K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,517 |
1,415 |
$21K |
| G0378 |
Hospital observation service, per hour |
330 |
142 |
$19K |
| 80074 |
|
639 |
522 |
$18K |
| 83880 |
|
745 |
676 |
$18K |
| 81003 |
|
10,163 |
9,224 |
$17K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
735 |
714 |
$17K |
| 87400 |
|
2,138 |
1,050 |
$16K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
581 |
432 |
$15K |
| 70450 |
Computed tomography, head or brain; without contrast material |
190 |
172 |
$15K |
| 82728 |
|
1,218 |
1,142 |
$15K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
429 |
393 |
$14K |
| 83021 |
|
914 |
765 |
$14K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
556 |
508 |
$13K |
| 86592 |
|
3,308 |
2,988 |
$13K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
256 |
241 |
$11K |
| 87081 |
|
1,640 |
1,559 |
$11K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
177 |
136 |
$11K |
| J1756 |
Injection, iron sucrose, 1 mg |
167 |
72 |
$10K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,346 |
1,234 |
$10K |
| 83020 |
|
992 |
764 |
$10K |
| 87340 |
|
1,124 |
1,039 |
$10K |
| 87634 |
|
165 |
148 |
$10K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
275 |
190 |
$9K |
| 73564 |
|
277 |
260 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,132 |
965 |
$9K |
| 84466 |
|
809 |
746 |
$8K |
| 83735 |
|
2,064 |
1,719 |
$8K |
| 80055 |
|
407 |
351 |
$8K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
130 |
118 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
357 |
296 |
$7K |
| 84439 |
|
754 |
694 |
$6K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
78 |
66 |
$5K |
| 85027 |
|
1,132 |
1,043 |
$5K |
| 82950 |
|
980 |
926 |
$4K |
| 83540 |
|
823 |
760 |
$4K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
28 |
25 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
338 |
312 |
$4K |
| 86762 |
|
325 |
284 |
$4K |
| 76830 |
Ultrasound, transvaginal |
50 |
50 |
$4K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
26 |
26 |
$4K |
| 73630 |
|
186 |
173 |
$4K |
| 86200 |
|
286 |
270 |
$3K |
| 84550 |
|
954 |
911 |
$3K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
93 |
39 |
$3K |
| 86850 |
|
614 |
514 |
$3K |
| 74019 |
|
80 |
78 |
$3K |
| 86593 |
|
738 |
686 |
$3K |
| 84702 |
|
208 |
153 |
$3K |
| 86696 |
|
131 |
123 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
59 |
55 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,038 |
1,743 |
$2K |
| 86038 |
|
181 |
172 |
$2K |
| 82962 |
|
848 |
755 |
$2K |
| 83970 |
|
131 |
125 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,004 |
881 |
$2K |
| 87807 |
|
149 |
143 |
$2K |
| 86695 |
|
130 |
123 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
836 |
753 |
$2K |
| 73030 |
|
54 |
50 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
228 |
215 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
48 |
44 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
247 |
228 |
$1K |
| 86901 |
|
617 |
514 |
$1K |
| 86900 |
|
612 |
514 |
$1K |
| 80069 |
|
278 |
251 |
$1K |
| 84153 |
|
68 |
66 |
$1K |
| 73562 |
|
52 |
50 |
$1K |
| 82570 |
|
275 |
259 |
$1K |
| 82043 |
|
204 |
193 |
$952.63 |
| 84100 |
|
334 |
195 |
$949.74 |
| 94760 |
|
131 |
110 |
$948.62 |
| 80081 |
|
15 |
12 |
$920.82 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
206 |
192 |
$662.51 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
320 |
275 |
$415.96 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
12 |
12 |
$378.72 |
| 80076 |
|
47 |
47 |
$350.14 |
| 86706 |
|
36 |
24 |
$335.90 |
| 83921 |
|
15 |
14 |
$300.76 |
| 85610 |
|
89 |
77 |
$276.82 |
| 86140 |
|
72 |
67 |
$269.16 |
| 81511 |
|
25 |
24 |
$266.55 |
| 84154 |
|
13 |
12 |
$224.92 |
| 90686 |
|
46 |
46 |
$207.12 |
| 82550 |
|
42 |
39 |
$198.14 |
| 80320 |
|
14 |
14 |
$190.19 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
102 |
95 |
$187.16 |
| 87070 |
|
51 |
41 |
$148.50 |
| 94761 |
|
15 |
14 |
$138.21 |
| 87075 |
|
39 |
29 |
$124.63 |
| J7510 |
Prednisolone oral, per 5 mg |
13 |
12 |
$121.80 |
| 85379 |
|
14 |
12 |
$113.91 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
75 |
41 |
$92.96 |
| 83605 |
|
15 |
13 |
$82.38 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
73 |
68 |
$72.31 |
| 82150 |
|
12 |
12 |
$65.82 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
32 |
27 |
$58.95 |
| J2704 |
Injection, propofol, 10 mg |
875 |
564 |
$54.46 |
| 82803 |
|
14 |
12 |
$50.38 |
| 85652 |
|
28 |
26 |
$46.74 |
| J1790 |
Injection, droperidol, up to 5 mg |
15 |
13 |
$30.59 |
| 84156 |
|
27 |
25 |
$30.13 |
| 99152 |
|
19 |
12 |
$20.78 |
| J2060 |
Injection, lorazepam, 2 mg |
36 |
33 |
$9.66 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
64 |
52 |
$4.33 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
241 |
202 |
$4.33 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
181 |
141 |
$2.72 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
75 |
62 |
$2.14 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
41 |
39 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
113 |
74 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
89 |
78 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
36 |
27 |
$0.00 |